Contact us: +91 9550333722 040 - 40102781
Structured search
India
Choose your country
Different countries will display different contents
Try our best to find the right business for you.
My chemicalbook

Welcome back!

HomeProduct name listILEPATRIL

ILEPATRIL

ILEPATRIL Structural

What is ILEPATRIL?

The Uses of ILEPATRIL

A dual angiotensin-converting enzyme and neutral endopeptidase inhibitor, for the potential treatment of hypertension and diabetic nephropathy. Ilepatril is currently in phase IIb/III clinical trials for hypertension and phase II trials for diabetic nephropathy.

Properties of ILEPATRIL

Boiling point: 693.7±55.0 °C(Predicted)
Density  1.31
pka 3.51±0.40(Predicted)

Safety information for ILEPATRIL

Computed Descriptors for ILEPATRIL

Related products of tetrahydrofuran

You may like

  • 40216-83-9 trans-4-Hydroxy-L-proline methyl ester hydrochloride 98+
    40216-83-9 trans-4-Hydroxy-L-proline methyl ester hydrochloride 98+
    40216-83-9
    View Details
  • 471-25-0 Propiolic Acid 98+
    471-25-0 Propiolic Acid 98+
    471-25-0
    View Details
  • 84145-28-8 98+
    84145-28-8 98+
    84145-28-8
    View Details
  • trans-3-Benzyloxy-4-methoxy-beta-nitrostyrene 98+
    trans-3-Benzyloxy-4-methoxy-beta-nitrostyrene 98+
    63909-29-5
    View Details
  • 2-(2-Chlorophenyl)glycine 88744-36-9 98+
    2-(2-Chlorophenyl)glycine 88744-36-9 98+
    88744-36-9
    View Details
  • 40216-83-9 trans-4-Hydroxy-L-proline methyl ester hydrochloride 98+
    40216-83-9 trans-4-Hydroxy-L-proline methyl ester hydrochloride 98+
    40216-83-9
    View Details
  • 629-76-5 98+
    629-76-5 98+
    629-76-5
    View Details
  • 1-(3-Hydroxy-4-methoxyphenyl)-2-nitroethene 98+
    1-(3-Hydroxy-4-methoxyphenyl)-2-nitroethene 98+
    39816-35-8
    View Details
Statement: All products displayed on this website are only used for non medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.